BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21724722)

  • 1. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic arthritis assessment tools in clinical trials.
    Mease PJ; Antoni CE; Gladman DD; Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.
    Coates LC; FitzGerald O; Mease PJ; Gladman DD; Strand V; Goel N; Campbell I; Krueger G; McHugh NJ; Helliwell PS
    J Rheumatol; 2014 Apr; 41(4):782-91. PubMed ID: 24488420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite measures in psoriatic arthritis: GRAPPA 2008.
    Gladman DD; Landewé R; McHugh NJ; Fitzgerald O; Thaci D; Coates L; Mease PJ; Qureshi AA; Krueger GG; Ritchlin CT; Kavanaugh AF; Garg A
    J Rheumatol; 2010 Feb; 37(2):453-61. PubMed ID: 20147481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
    Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
    J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.
    Helliwell PS; FitzGerald O; Fransen J
    J Rheumatol; 2014 Jun; 41(6):1212-7. PubMed ID: 24882854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.
    Helliwell PS; Fitzgerald O; Strand CV; Mease PJ
    J Rheumatol; 2011 Mar; 38(3):540-5. PubMed ID: 21362782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
    Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
    J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus on a core set of domains for psoriatic arthritis.
    Gladman DD; Mease PJ; Strand V; Healy P; Helliwell PS; Fitzgerald O; Gottlieb AB; Krueger GG; Nash P; Ritchlin CT; Taylor W; Adebajo A; Braun J; Cauli A; Carneiro S; Choy E; Dijkmans B; Espinoza L; van der Heijde D; Husni E; Lubrano E; McGonagle D; Qureshi A; Soriano ER; Zochling J
    J Rheumatol; 2007 May; 34(5):1167-70. PubMed ID: 17477480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.
    Healy PJ; Helliwell PS
    Arthritis Rheum; 2008 May; 59(5):686-91. PubMed ID: 18438903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
    Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
    J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus exercise on domains in psoriatic arthritis.
    Gladman DD
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii113-4. PubMed ID: 15708924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
    Helliwell PS; Fitzgerald O; Mease PJ
    J Rheumatol; 2012 Feb; 39(2):398-403. PubMed ID: 22298265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
    Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
    Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting.
    Helliwell PS; Fitzgerald O; Mease PJ; Gladman DD
    J Rheumatol; 2012 Nov; 39(11):2196-7. PubMed ID: 23118286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.
    Callis Duffin K; Mease PJ
    J Rheumatol; 2011 Mar; 38(3):562-3. PubMed ID: 21362788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.